Molnupiravir was one of the first antivirals available on the market during the COVID-19 pandemic, and was employed by many countries, including the US, particularly against chronic infections. By IAN RANDALL Daily Express Mon, Sep 25, 2023 A drug widely used against COVID-19 is driving an unintended pattern of mutations in SARS-CoV-2 (Image: Getty Images) An antiviral […]
SEP 29, 2023 – 07:20 AM Authored by Jack Phillips via The Epoch Times After multiple weeks of increasing COVID-19 hospital admissions, federal data show that the figure is now falling. In the week ending Sept. 16, U.S. Centers for Disease Control and Prevention (CDC) data show hospitalizations are down 4.3 percent. The number had been increasing […]
Panagis Galiatsatos, M.D., M.H.S. February 28, 2022 John’s Hopkins Like other respiratory illnesses, COVID-19 can cause lasting lung damage. “As we continue to learn about COVID-19, we’re understanding more regarding how it affects the lungs during acute illness and afterward. And this is especially true with the virus’ ongoing variants, as well,” Galiatsatos says. What […]
SEP 22, 2023 – 02:25 PM Authored by Naveen Athrappully via The Epoch Times Wastewater COVID levels have shown a decline in recent weeks while the number of hospital admissions due to infections have seen an uptick. The levels of SARS-CoV-2 virus, which causes the COVID-19 infection, has dropped by 5 percent in the two weeks […]
By Assistant Editor Sep. 22, 2023 By Wayne Allyn Root Gateway Pundit (Opinion Piece–Make up Your Own Mind & Do Your Own Research) Does the media ever wonder why so few Americans want the new Covid booster shot? Or why so few Americans wanted the last booster shot? I know why. It’s because almost everyone (who isn’t […]
Story by Nacha Cattan Sept 21, 2023 Bloomberg A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday.© Bloomberg (Bloomberg) — In a real-world study of people with Covid-19, Pfizer Inc.’s antiviral Paxlovid was less effective at […]
by Erik Robinson, Oregon Health & Science University JANUARY 25, 2023 Immunity from COVID-19 appears to gather strength with more time between vaccination and infection, a new laboratory study from researchers at Oregon Health & Science University suggests. The findings carry implications for vaccine recommendations as the pandemic transitions to an endemic state. Researchers measured the […]
There is no cure or approved treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, some symptoms can be treated or managed. Treating these symptoms might provide relief for some patients with ME/CFS but not others. Other strategies, like learning new ways to manage activity, can also be helpful. Patients, their families, and healthcare providers need […]
Mark Barash, DOa,∗ and Vijaya Ramalingam, MD, FCCPa,b Clin Chest Med. 2023 Jun; 44(2): 263–277. Published online 2023 Mar 3. doi: 10.1016/j.ccm.2022.11.019 PMCID: PMC9983785 PMID: 37085219 Author information Copyright and License information PMC Disclaimer As the world emerges from the COVID-19 pandemic, clinicians and researchers across the world are trying to understand the sequelae in patients recovered from COVID-19 infection. In this article, the […]
Sergey Knyazev, Karishma Chhugani, Varuni Sarwal, Ram Ayyala, Harman Singh, Smruthi Karel O. Wertheim, Braden T. Tierney, Charles Y. Chiu, Ren Sun, Aiping Wu, Malak S. Abedalthagafi, Victoria M. Pak, Shivashankar H. Nagaraj, Adam L. Smith, Pavel Skums, Bogdan Pasaniuc, Andrey Komissarov, Serghei Mangul Nature Methods volume 19, pages374–380 (2022) Cite this article 9048 Accesses,17 Citations, 41 Altmetric, Metrics details During the COVID-19 pandemic, genomics and bioinformatics have emerged as essential public health tools. The genomic data acquired […]